Levels of choline acetyltransferase (ChAT) and acetylcholinesterase (AchE), major markers of cholinergic neuronal activity, are reduced in the late stage of Alzheimer’s disease, which contributes to cognitive deficits (H. Ferreira-Vieira et al., 2016). This evidence concerns the gene ACHE and Cognitive impairment.